جست‌وجوی استاد و پژوهشگر

Negin Fouladiمشاهده پروفایل

دانشیار بالینی

• Health Policy
• Public Health Practice and Policy
• Value-Based Care
• +۵ مورد دیگر

Dr. Negin Fouladi is an Associate Clinical Professor in the Department of Health Policy and Management at the University of Maryland's School of Public Health. She serves as Program Director and academic/career development advisor for online MPH and MHA programs, overseeing courses on health systems, policy, strategic planning, and global health. Her research focuses on Translational Science (T3/T4), knowledge translation, value-based care, comparative health systems, and evidence-informed policymaking. Education: PhD in Health Policy, University of Texas School of Public Health MPH in Health Services Organizations, University of Texas School of Public Health MS and BS in Biological Sciences, University of Houston-Clear Lake Research Interests: Dr. Fouladi's work emphasizes translating research into practice through initiatives like the International Virtual Health Research Exchange (U21HREx), a global network fostering mentorship and collaboration among early-career health researchers. She evaluates healthcare systems' performance, particularly in transitioning to value-based models, and analyzes decision-makers' information needs in diverse health systems. Professional Contributions: As evaluator of the CTSA Program and chair of U21HREx, she bridges academic research with real-world policy applications. Her work strengthens international health partnerships and trains future healthcare leaders through collaborative academic initiatives.

Byung-Eun Kimمشاهده پروفایل

دانشیار

• Copper Homeostasis
• Metallomics
• Cellular Signaling
• +۳ مورد دیگر

Dr. Byung-Eun Kim is an Associate Professor in the Department of Animal & Avian Sciences at the University of Maryland, College Park. His research focuses on understanding copper homeostasis mechanisms across cellular, organismal, and behavioral levels, with particular emphasis on cardiomyopathy risk factors and C. elegans models of copper deficiency. His lab investigates systemic copper signaling pathways, inter-organ communication, and molecular mechanisms of copper distribution in worms and mammals. Key research areas include: Copper transporters (CTR1, ATP7A/B) Copper-related genetic disorders (Menkes/Wilson diseases) Therapeutic applications of elesclomol Mitochondrial dysfunction and immunosuppression Recent work highlights innovative C. elegans models and mitochondrial studies, with publications spanning from 2002 to 2024. His research bridges basic science and translational medicine, addressing critical gaps in copper metabolism understanding. Lab website: kimlabumd.com

• Non-coding RNAs
• Pulmonary Fibrosis
• Cystic Fibrosis
• +۴ مورد دیگر

Chiara De Santi is a Lecturer in Immunology at the School of Pharmacy and Biomolecular Sciences , Royal College of Surgeons in Ireland (RCSI), Dublin. She holds a PhD from the University of Siena and has held academic roles including Postdoctoral Researcher (2016–2020) and Research Fellow (2021–2022). Her research focuses on non-coding RNAs' therapeutic potential in lung diseases such as cystic fibrosis and pulmonary fibrosis, employing stem cell-derived organoids and ALI cultures for drug discovery. Education: BSc in Biological Sciences, University of Pisa (2007–2010) MSc in Molecular Biology, University of Pisa (2010–2012) PhD in Molecular Medicine, University of Siena (2012–2016) Research Interests: Non-coding RNAs (miRNAs, circRNAs) in lung pathologies Stem cell models for disease modeling Therapeutic modulation of inflammatory responses Cystic fibrosis and pulmonary fibrosis mechanisms Grants & Funding: RCSI Grant: The role of non-coding RNAs in alveolar epithelial damage (2023–2026) Vertex Pharmaceuticals: Target site blockers for CFTR mutation therapy (2024–2027) Irish Research Council: miRNA therapeutics in multiple sclerosis (2018–2020) Professional Activities: Athena Swan Champion for PBS (2023–present) RCSI EDI Committee and PPI in Research Committee member Chair of RCSI Postdoc Society (2021–2022) Teaching: Immunology modules for medical and biomedical science programs Leadership in Year 1 Prize Medal Dissertation Competition (Medicine) Contributions to MSc programs in Precision Medicine

• HIV neuroinfection and cure
• Drug abuse and neurological behavior
• Drug discovery
• +۴ مورد دیگر

Dr. Jason Paris is a Research Associate Professor in the Department of BioMolecular Sciences at the University of Mississippi School of Pharmacy. His laboratory investigates neurodegenerative disease pathology associated with addiction and neuroHIV, employing behavioral, cellular, and molecular techniques to develop therapeutic interventions. Research focuses on neuroendocrine dysfunction, immune modulation, and pharmacological strategies to mitigate neurocognitive decline. Education includes a Ph.D. in Behavioral Neuroscience from The University at Albany-SUNY and a B.S. from Marywood University. Research interests encompass HIV neuropathology, substance abuse neurobiology, and neuroendocrine-immune interactions. Publications demonstrate consistent focus on neuroHIV mechanisms and therapeutic interventions, with recent emphasis on mitochondrial dysfunction, neurosteroid pathways, nanoparticle delivery systems, and gender-specific neuropathology. Methodologies include transgenic models, molecular biology, and behavioral assays. Laboratory collaborations include chemists and bioengineers to develop novel compounds targeting addiction and neuroHIV. Current work emphasizes neuroprotective strategies using natural compounds and pharmacological agents to modulate stress responses and neuroinflammation.

Lawrence Lashمشاهده پروفایل

استاد

• Pharmacology
• Toxicology
• Renal Injury Mechanisms
• +۴ مورد دیگر

Dr. Lawrence Lash is a Professor of Pharmacology at Wayne State University, Detroit, Michigan. With a career spanning nearly four decades, his work focuses on renal toxicology, specifically mechanisms of chemical-induced kidney injury and biomarker development. PhD in Biochemistry (Emory University, 1985) Postdoc in Pharmacology & Toxicology (University of Rochester, 1985-1986) Wayne State faculty since 1988 (Assistant → Associate → Full Professor) Research highlights include discovery of the sodium-coupled GSH transporter in renal membranes, characterization of mitochondrial targets for halogenated solvents, and development of human proximal tubular cell models for drug toxicity screening. Current work explores mitochondrial proteomics and lipidomics as early biomarkers for environmental and pharmacologic nephrotoxicity. His laboratory utilizes in vitro systems (primary human/rat proximal tubular cells) and in vivo models to study: Sex- and species-specific differences in toxicant metabolism Role of mitochondrial carriers (DIC, OGC) in GSH transport Adaptive changes in diabetes-related renal stress Dr. Lash serves editorial roles at Toxicology Reports (Founding Editor-in-Chief) and Toxicology and Applied Pharmacology , and contributes to U.S. EPA advisory committees. He teaches graduate courses including Advanced Topics in Pharmacology and Principles of Toxicology .

Kisuk Minمشاهده پروفایل

استادیار

• Exercise Physiology
• Skeletal Muscle Biology
• Cardiac Muscle Function
• +۳ مورد دیگر

Dr. Kisuk Min is an Assistant Professor in the Department of Kinesiology at the University of Texas at El Paso. His research focuses on molecular mechanisms underlying muscle and cardiac adaptations to injury, disease, and exercise. He earned his Ph.D. in Exercise Physiology from the University of Florida and completed postdoctoral training at Yale University School of Medicine. Dr. Min's work investigates signaling pathways involved in skeletal and cardiac muscle protection, particularly targeting mitochondrial function, MAPK regulation, and doxorubicin cardiotoxicity. His studies use mouse models and cell cultures to explore exercise-induced therapeutic interventions for muscle atrophy, dystrophy, and metabolic disorders. Recent research highlights include exploring neuromuscular electrical stimulation for glycemic control, MKP phosphatase roles in metabolic and cardiac adaptations, and mechanistic links between exercise and chemotherapy-induced cardiotoxicity prevention. His studies frequently intersect muscle metabolism, cellular stress responses, and translational medicine applications. Education: PhD in Exercise Physiology, University of Florida Postdoctoral Training: Yale University School of Medicine Key research themes include: Muscle disease mechanisms and therapies Mitochondrial signaling in metabolic disorders Exercise interventions for cardioprotection MAP kinase phosphatase signaling networks His funded projects examine how cellular signaling pathways modulate skeletal/cardiac muscle responses to stressors like chemotherapy, mechanical ventilation, and disuse atrophy. Current work explores novel therapeutic targets for cardiomyopathy and metabolic syndrome.

J. Scott Christiansonمشاهده پروفایل

عضو هیئت علمی

• Artificial Intelligence
• Blockchain Technology
• Entrepreneurship
• +۴ مورد دیگر

J. Scott Christianson is an Associate Teaching Professor in the Management Department and Director of the Center for Entrepreneurship and Innovation at the University of Missouri’s Robert J. Trulaske, Sr., College of Business. He specializes in emerging technologies, project management, and educational innovation, with a focus on integrating AI, blockchain, and IoT into curricula. Christianson has held faculty roles since 2014 and previously owned Kaleidoscope Consulting (1998–2019), a firm specializing in videoconferencing solutions. Education: MA in Education and Human Development from The George Washington University (1999) and BA in Biology from the University of Missouri (1991). Research & Teaching: Develops courses on management information systems, entrepreneurial ventures, and digital transformation. His work emphasizes critical thinking about technologies like blockchain and AI, and he has authored textbooks and numerous articles on these topics. Awards: Multiple teaching honors including the Raymond O’Brien Award (2017), Distance Learning Leadership Award (2009), and Top 20 Under 40 (2007). Recognized for contributions to edtech, including pioneering work in interactive television and videoconferencing. Grants & Leadership: Secured grants for integrating clinical simulations into courses and improving project management education. Served on boards such as the State Technical College of Missouri and Boone County Industrial Development Authority. Active in community initiatives like broadband planning and K–12 technology advocacy. Publications: Over 100 works, including books on certification, project management, and educational tech, plus peer-reviewed articles in vision science and computer security. Regular contributor to media discussions on AI, cryptocurrency, and digital ethics.

Holly LaVoieمشاهده پروفایل

استاد

• Ovarian Biology
• Steroidogenesis
• Reproductive Endocrinology
• +۳ مورد دیگر

Holly LaVoie is Professor of Cell Biology & Anatomy at the University of South Carolina School of Medicine, where she leads research on ovarian physiology and reproductive endocrinology. Her laboratory investigates hormonal control of follicular development using molecular and biochemical approaches. Education: PhD in Physiology, Medical College of Virginia MA in Biology, College of William and Mary BS in Biology, College of William and Mary Her research program examines transcriptional regulation of steroidogenesis in ovarian cells, with emphasis on cholesterol transport proteins (STARD family) and their role in follicular development. Clinical translation focuses on identifying biomarkers of oocyte quality for assisted reproduction, particularly in cumulus cells. Recent publications demonstrate extensive use of molecular techniques (80% of output), with human studies examining IVF outcomes and animal models elucidating fundamental mechanisms. Emerging interests include maternal cardiovascular adaptations during pregnancy and metabolic aspects of ovarian function. Professor LaVoie teaches health economics and research methods in graduate programs. She serves as reviewer for NIH study sections and international journals including Endocrinology and Biology of Reproduction. Her laboratory collaborates with clinical IVF programs to translate basic research findings into improved reproductive outcomes. Current projects investigate mitochondrial metabolism in granulosa cells and extracellular matrix remodeling in maternal cardiac tissue.

S. Michal Jazwinskiمشاهده پروفایل

استاد

• Genetics of Aging
• Molecular Genetics
• Population Genetics
• +۳ مورد دیگر

S. Michal Jazwinski is the John W. Deming, MD Regents Chair in Aging and Professor of Medicine and Biochemistry at Tulane University School of Medicine. He directs the Tulane Center for Aging, focusing on the genetics of aging, molecular genetics, and population genetics. His career includes postdoctoral training at The Rockefeller University and prior roles at Louisiana State University. Research interests span yeast replicative lifespan mechanisms, mitochondrial dysfunction, and human aging biomarkers. Key contributions include studies on the retrograde response, inflammaging, and the role of microbiome-immune interactions in aging. Jazwinski has edited books on circadian rhythms and aging and authored over 150 peer-reviewed articles. Education: PhD in Biochemistry, Stanford University (1975) Key Roles: Director of Tulane Center for Aging, Member of Tulane Cancer Center's Cancer Biology Program Affiliations: Tulane Cancer Center, Tulane Center for Aging, Biochemistry (adjunct), Geriatrics Division His work integrates genetics, epigenetics, and systems biology to explore aging mechanisms in both model organisms and humans. Current projects include frailty index development, biological age measurement, and mitochondrial signaling pathways in cancer. Major findings include the role of Th17 immunity in aging-related inflammation, gut microbiome impacts on healthspan, and novel mouse models for prostate cancer research.

Siyaram Pandeyمشاهده پروفایل

استاد

• Oxidative Stress in Aging and Neurodegeneration
• Cancer Biology and Therapy
• Natural Products as Anticancer Agents
• +۳ مورد دیگر

Dr. Siyaram Pandey is a Professor in the Department of Chemistry and Biochemistry at the University of Windsor's Faculty of Science. His research focuses on oxidative stress in neurodegenerative diseases, anticancer therapies using natural products, and neuroprotection strategies. He earned his Ph.D. in Biochemistry from Jawaharlal Nehru University, New Delhi. Education: Ph.D. in Biochemistry, Jawaharlal Nehru University (J.N.U.), New Delhi Research Interests: Oxidative Stress in Aging and Neurodegeneration Development of Single Domain Antibodies Against Pro-Apoptotic Proteins Anti-Cancer Efficacy of Natural Compounds (e.g., Lemongrass, Dandelion) Role of Mitochondrial Vulnerabilities in Cancer Therapy Research Highlights: Investigating Ubisol-Q10 (water-soluble CoQ10) for Alzheimer’s and Parkinson’s neuroprotection Exploring natural extracts (e.g., Curcumin analogs, Long Pepper) to enhance chemotherapy efficacy Targeting apoptosis pathways in cancer cells using plant-derived compounds Advising & Grants: Lab work focuses on translational research in oncology and neurodegenerative diseases Collaborations with chemists and biomedical researchers to develop novel therapies Labs/Teams: The Pandey Lab at the University of Windsor, specializing in biochemistry, drug discovery, and translational medicine.

• Exercise Physiology
• Metabolic Disease
• Type 2 Diabetes
• +۵ مورد دیگر

Gordon Fisher is a Professor in the School of Education's Human Studies department at the University of Alabama at Birmingham (UAB), where he also serves as Assistant Dean of Research. His academic appointments include Professor in Human Studies (since 2013), Assistant Professor in Nutrition Sciences, and Senior Scientist positions in multiple UAB research centers including the Nutrition Obesity Research Center, Center for Clinical and Translational Science, and Comprehensive Diabetes Center. Dr. Fisher's research focuses on developing nutritional and behavioral strategies to reduce metabolic and cardiovascular complications associated with type 2 diabetes, with particular interest in the mechanistic role of mitochondrial bioenergetics and redox signaling in diabetes pathogenesis. His work spans exercise physiology, metabolic disease, vascular health, and innovative telehealth exercise interventions for special populations including wheelchair users and individuals with spinal cord injury. Analysis of his 15 most recent publications reveals a strong emphasis on high-intensity interval training, vascular hemodynamics, mitochondrial function, and nutritional interventions (particularly beetroot juice/nitrate supplementation) for improving cardiometabolic health. His research demonstrates significant racial and sex differences in physiological responses to exercise and dietary interventions, with particular attention to African American women's cardiovascular responses. Dr. Fisher serves as an active member of the American College of Sports Medicine, American Physiological Society, and The Obesity Society. He is an ad hoc reviewer for numerous journals including Obesity, Journal of Gerontology, and Medicine and Science in Sports and Exercise, and serves on editorial boards for PLOS One, Journal of Sport and Human Performance, and Obesity: Open Access. His teaching philosophy emphasizes providing students with knowledge, skills, and leadership to succeed in their fields, with particular focus on keeping up with current research in exercise physiology. He has served on multiple graduate thesis committees and teaches various courses in physiology and kinesiology. Dr. Fisher leads several NIH-funded research projects including telehealth exercise interventions for wheelchair users (funded by National Institute of Child Health and Human Development), high-intensity interval training for spinal cord injury (funded by National Institute of Nursing Research), and research on race-adiposity interactions in insulin sensitivity (funded by National Institute of Diabetes and Digestive and Kidney Diseases).

Renita Hortonمشاهده پروفایل

استادیار

• Cardiovascular Engineering
• Tissue Engineering
• Sickle Cell Disease
• +۵ مورد دیگر

Renita Horton is an Assistant Professor in the Department of Biomedical Engineering at the University of Houston’s Cullen College of Engineering. She joined UH in 2019 after serving as an Assistant Professor at Mississippi State University, where she established the Cardiovascular Tissue Engineering Laboratory. Her research focuses on understanding mechanisms driving heart disease, lupus, and sickle cell anemia to improve clinical outcomes. Horton holds a Ph.D. and M.S. in Engineering Sciences from Harvard University (with a bioengineering focus) and a B.S. in Chemical Engineering from Mississippi State University. Education: Ph.D., Engineering Sciences (Bioengineering Concentration), Harvard University M.S., Engineering Sciences, Harvard University B.S., Chemical Engineering, Mississippi State University Research Interests: Horton’s lab develops biomimetic microsystems to study cardiovascular diseases, particularly leveraging organ-on-a-chip technology. Key areas include modeling sickle cell vaso-occlusions, cardiac fibrosis mechanisms, and lupus-related cardiac complications. Her work integrates microfluidics, computational modeling, and stem cell engineering to bridge basic science and clinical applications. Awards & Honors: National Science Foundation (NSF) CAREER Award Lupus Research Alliance Empowering Lupus Research Career Development Award Grants & Advising: Horton’s NSF-funded CAREER project investigates congenital heart-on-a-chip systems for cardiac fibrosis research. She actively mentors students in interdisciplinary cardiovascular engineering projects. Her lab collaborates across biomedical, chemical, and materials engineering disciplines. Labs & Teams: Director of the Cardiovascular Tissue Engineering Laboratory (CTEL) at UH, which focuses on translational cardiovascular research. Collaborates with institutions like Harvard’s Wyss Institute and the American Heart Association.

Ioanna Andreadouمشاهده پروفایل

استاد

• Cardiovascular Pharmacology
• Cardioprotection
• Cardio-Oncology
• +۵ مورد دیگر

Ioanna Andreadou is Professor of Pharmaceutical Chemistry at the National and Kapodistrian University of Athens, School of Pharmacy, where she leads cardiovascular pharmacology research. With over 35 years of academic experience, she directs the Section of Pharmaceutical Chemistry and serves as Vice Chair of the Hellenic Society of Basic and Clinical Pharmacology. Her work bridges molecular pharmacology and clinical translation in cardioprotection. Education: Degree in Pharmacy, Aristotle University of Thessaloniki (1988) PhD in Pharmacology, Aristotle University of Thessaloniki (1994) Post-doctoral training: Leiden Amsterdam Center for Drug Research/Vrije Universiteit Amsterdam (1994-1996) Post-doctoral training: The Hatter Cardiovascular Institute, University College London (2009) Her research focuses on molecular mechanisms of cardioprotection against ischemia/reperfusion injury, with emphasis on mitochondrial targets , redox signaling , and cardio-oncology . She pioneers investigations into drug-induced cardiotoxicity (particularly from proteasome inhibitors like carfilzomib) and natural product-based cardioprotective strategies (e.g., olive polyphenols). Her lab integrates preclinical models (murine, porcine), clinical pharmacology , and molecular screening to identify novel therapeutic targets for myocardial protection. Analysis of her recent publications (2023-2025) reveals three dominant trends: (1) SGLT2 inhibitors (especially empagliflozin) for endothelial protection in acute MI, (2) cardio-oncology mechanisms involving immune checkpoint inhibitors and proteasome inhibitors, and (3) mitochondrial targets for clinical translation. Her work increasingly employs multicenter preclinical studies (e.g., IMPACT initiative) and translational biomarkers related to endothelial glycocalyx and immune-metabolic crosstalk. Scientific distinctions: State Scholarship Foundation PhD Grant (1988-1991) Human Capital and Mobility Post-doctoral Fellowship (1994) European Science Foundation Fellowship (1995) Hellenic Society of Cardiology Training Grant (2007) Visiting Professorship at University of Turin (2017) As Editorial Board member for British Journal of Pharmacology and Basic Research in Cardiology , she shapes cardiovascular research discourse. Her grant leadership includes coordinating the EU-Cardioprotection COST Action network and securing Hellenic Society of Cardiology funding for cardio-oncology studies. She serves on Greece's National Drug Organization Scientific Council and Ministry of Health Narcotics Council. She leads a multidisciplinary research team within the Pharmaceutical Chemistry Section, collaborating with University College London's Hatter Institute and the European Network EU-Cardioprotection. Current projects include the IMPACT multicenter study on cardioprotective therapies and investigations into SGLT2 inhibitors' mechanisms beyond glucose control.

Paul Dalhaimerمشاهده پروفایل

دانشیار

• Nanoparticle Drug Delivery
• Biomedical Engineering
• Cell Biology
• +۵ مورد دیگر

Paul Dalhaimer is an Associate Professor in the Department of Chemical and Biomolecular Engineering at the University of Tennessee, Knoxville, within the Tickle College of Engineering. His research focuses on nanoparticle design for drug delivery, lipid droplet dynamics, and molecular mechanisms of autophagy. He holds a BS and PhD in Chemical Engineering from the University of Pennsylvania and completed a postdoctoral fellowship at Yale University studying actin cytoskeleton dynamics. Research Interests: Engineering nanoparticles with optimized biological interactions Autophagy regulation in disease contexts Lipid droplet formation and breakdown pathways Molecular dynamics simulations of biological systems Recent work highlights nanoparticle interactions with macrophages, obesity's effects on drug delivery, and SR-BI receptor targeting strategies. His studies integrate biophysical modeling with in vitro and in vivo experiments to bridge nanotechnology and clinical applications. His scientific contributions emphasize translational research at the interface of chemical engineering and biomedical science, with a focus on improving drug delivery systems through fundamental mechanistic insights.

J. Dafhne Aguirreمشاهده پروفایل

دانشیار

• Biochemistry
• Molecular Biology
• Chemical Biology
• +۳ مورد دیگر

J. Dafhne Aguirre is an Associate Professor in Residence at the University of Connecticut , affiliated with the Department of Chemistry . Her academic journey includes a Postdoctoral Fellowship at Johns Hopkins University , a Ph.D. from Texas A&M University , and a B.Sc. from Pontificia Universidad Catolica del Peru . Education: Postdoctoral Fellow, Johns Hopkins University Ph.D., Texas A&M University B.Sc., Pontificia Universidad Catolica del Peru Dr. Aguirre’s research spans Biochemistry , Molecular Biology , and Chemical Biology , with a focus on ubiquitination mechanisms , DNA repair pathways , and metal-based anticancer compounds . Her work explores the structural and functional dynamics of proteins like parkin and UBR5, as well as the photophysical properties of dirhodium complexes. Recent publications highlight advancements in ubiquitin signaling , mitochondrial quality control , and metallodrug design . Her studies on dirhodium complexes for DNA photocleavage and anticancer activity demonstrate applications in Medicinal Chemistry and Photochemistry . Contact: jdaguirre@uconn.edu | Phone: (860) 486-3217